FT

EU bets on BioNTech/Pfizer jab as Danes end use of AstraZeneca

Brussels puts focus on mRNA vaccines amid concern over rare blood clots linked to other shots

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Back to top button